Hydroxychloroquine is a drug used to prevent and treat certain types of malaria. Specifically, it is used for chloroquine-sensitive malaria. Other uses include the treatment of rheumatoid arthritis, lupus and cutaneous porphyria. It is also used as an experimental treatment for coronavirus disease (COVID-19) in 2019.

Market Analysis and Insights: Global Hydroxychloroquine Market
In 2020, the global Hydroxychloroquine market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Hydroxychloroquine Scope and Market Size
The global Hydroxychloroquine market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Hydroxychloroquine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
100 mg
200 mg
Other

Segment by Application
Lupus Erythematosus
Rheumatoid Arthritis
Others

By Company
Sanofi
Novartis
Shanghai Zhongxisanwei
Teva
Zydus Cadila
Mylan
Apotex
Advanz Pharma
Sun Pharma
Kyung Poong
Ipca Laboratories
Hanlim Pharmaceutical
Bristol Laboratories

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE